Form 483

Uptite Company, Inc. Form 483, 2015-09-01

FDA issued a Form 483 to Uptite Company, Inc. on 2015-09-01 with 11 public-safe observations.

483· Form 483 issuedAnimal Drugs & Feeds11 observations

Uptite Company, Inc. · Haverhill, United States · Issued September 1, 2015

Overview

  • 11 public-safe observations are available for this inspection.
  • 11 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

1 Sep 2015
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Robert J Martin

1 Sep 2015
21 CFR 211.103

Actual vs. theoretical yields not determined

Cited by Robert J Martin

1 Sep 2015
21 CFR 211.110(c)

In-process materials characteristics testing

Cited by Robert J Martin

1 Sep 2015
21 CFR 211.165(a)

Testing and release for distribution

Cited by Robert J Martin

1 Sep 2015
21 CFR 211.166(a)

Lack of written stability program

Cited by Robert J Martin

Inspected site

UCUptite Company, Inc.Haverhill, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.103Cited across public-safe Form 483 observations1x
21 CFR 211.110(c)Cited across public-safe Form 483 observations1x
21 CFR 211.165(a)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.188(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.28(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(b)Cited across public-safe Form 483 observations1x
21 CFR 211.67(c)Cited across public-safe Form 483 observations1x
21 CFR 211.84(a)Cited across public-safe Form 483 observations1x
21 CFR 211.94(c)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 11 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere